World's Best Scientists 2026 revealed!
William J. Harrington

William J. Harrington

D-Index & Metrics

Immunology

D-Index
53
Citations
11890
World Ranking
3962
National Ranking
1814

William J. Harrington publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where William J. Harrington sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 168 publications — 23rd percentile

23% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

William J. Harrington D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where William J. Harrington sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 53 D-Index — 20th percentile

20% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

William J. Harrington was affiliated with the University of Miami in the United States. Their research spanned several interrelated fields within medicine, with a focus on oncology, immunology, and neurology.

Their work primarily addressed topics including:

  • Viral-associated cancers and disorders
  • Chronic Lymphocytic Leukemia Research
  • Lymphoma Diagnosis and Treatment
  • Parkinson's Disease Mechanisms and Treatments
  • Neurological disorders and treatments
  • Attention Deficit Hyperactivity Disorder
  • Extracellular vesicles in disease

Harrington regularly published in venues such as:

  • UNC Libraries
  • Journal of Parkinson s Disease
  • Animals

Frequent co-authors in their research included:

  • Dirk P. Dittmer
  • Iguaracyra Araújo
  • Andrea O'Hara
  • Estela Luz
  • Carlos Brites

Among their recent papers were:

  • The D1/D5 Dopamine Partial Agonist PF-06412562 in Advanced-Stage Parkinson's Disease: A Feasibility Study (2020), published in Journal of Parkinson s Disease
  • EBV MicroRNAs in Primary Lymphomas and Targeting of CXCL-11 by ebv-mir-BHRF1-3 (2020), published by UNC Libraries
  • Pre-Micro RNA Signatures Delineate Stages of Endothelial Cell Transformation in Kaposi Sarcoma (2020), published by UNC Libraries
  • Nuclear factor kappa B pathway associated biomarkers in AIDS defining malignancies (2020), published by UNC Libraries
  • Burkitt Lymphoma in Brazil Is Characterized by Geographically Distinct Clinicopathologic Features (2020), published by UNC Libraries

Harrington's specialization incorporated multiple subfields such as oncology, immunology, neurology, genetics, and pathology and forensic medicine. Their research often explored the molecular biology underlying disease mechanisms, with a notable attention to viral interactions in cancers and immunological disorders.

Throughout their career, Harrington contributed to advancing the understanding of diverse medical challenges, particularly those related to viral-associated malignancies and neurodegenerative diseases.

Best Publications

  • Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells.

    Esther A. Obeng;Louise M. Carlson;Delia M. Gutman;William J. Harrington

  • Demonstration of a thrombocytopenic factor in the blood of patients with thrombocytopenic purpura.

    William J. Harrington;Virginia Minnich;James W. Hollingsworth;Carl V. Moore

  • Definition, Prognostic Factors, Treatment, and Response Criteria of Adult T-Cell Leukemia-Lymphoma: A Proposal From an International Consensus Meeting

    Kunihiro Tsukasaki;Olivier Hermine;Ali Bazarbachi;Lee Ratner

  • IMMUNOLOGIC MECHANISMS IN IDIOPATHIC AND NEONATAL THROMBOCYTOPENIC PURPURA

    William J. Harrington;Charles C. Sprague;Virginia Minnich;Carl V. Moore

  • Apoptosis: Programmed cell death at a molecular level

    Duane R. Schultz;William J. Harrington

  • Meta-Analysis on the Use of Zidovudine and Interferon-Alfa in Adult T-Cell Leukemia/Lymphoma Showing Improved Survival in the Leukemic Subtypes

    Ali Bazarbachi;Yves Plumelle;Juan Carlos Ramos;Patricia Tortevoye

  • EBV microRNAs in primary lymphomas and targeting of CXCL-11 by ebv-mir-BHRF1-3.

    Tianli Xia;Andrea O'Hara;Iguaracyra Araujo;Jose Barreto

  • Danazol for the Treatment of Idiopathic Thrombocytopenic Purpura

    Yeon S. Ahn;William J. Harrington;William J. Harrington;Sheryl R. Simon;Sheryl R. Simon;Ravindra Mylvaganam;Ravindra Mylvaganam

  • Chemotherapy for Human Immunodeficiency Virus–Associated Non-Hodgkin’s Lymphoma in Combination With Highly Active Antiretroviral Therapy

    Lee Ratner;Jeannette Lee;Shenghui Tang;David Redden

  • Intestinal strongyloidiasis: recognition, management, and determinants of outcome.

    Ronald Concha;William Harrington;Arvey I Rogers

  • HHV-8 encoded vIRF-1 represses the interferon antiviral response by blocking IRF-3 recruitment of the CBP/p300 coactivators.

    Rongtuan Lin;Pierre Genin;Yael Mamane;Marco Sgarbanti;Marco Sgarbanti

  • Vincristine Therapy of Idiopathic and Secondary Thrombocytopenias

    Yeon S. Ahn;William J. Harrington;Robert C. Seelman;Charles S. Eytel

  • Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Interacts with Bromodomain Protein Brd4 on Host Mitotic Chromosomes

    Jianxin You;Viswanathan Srinivasan;Gerald V. Denis;William J. Harrington

  • Rapamycin is efficacious against primary effusion lymphoma (PEL) cell lines in vivo by inhibiting autocrine signaling

    Sang Hoon Sin;Debasmita Roy;Ling Wang;Michelle R. Staudt

  • The Treatment of Idiopathic Thrombocytopenia with Vinblastine-Loaded Platelets

    Yeon S. Ahn;John J. Byrnes;William J. Harrington;Marilyn L. Cayer

  • Identification of human T cell lymphotropic virus type IIa infection in the Kayapo, an indigenous population of Brazil.

    Ricardo Ishak;William J. Harrington;Vania N. Azevedo;Nobutaka Eiraku

  • Distinct Subsets of Primary Effusion Lymphoma Can Be Identified Based on Their Cellular Gene Expression Profile and Viral Association

    Wen Fan;Darya Bubman;Amy Chadburn;William J. Harrington

  • Activation of HHV-8 by HIV-1 tat

    William Harrington;Laura Sieczkowski;Carlos Sosa;Sharon Chan-a-Sue

  • Spastic ataxia associated with human T-cell lymphotropic virus type II infection

    William J. Harrington;William Sheremata;Brain Hjelle;Dipak K. Dube

  • Long-term danazol therapy in autoimmune thrombocytopenia: unmaintained remission and age-dependent response in women.

    Yeon S. Ahn;Rafael Rocha;Ravindra Mylvaganam;Rolando Garcia

Frequent Co-Authors

Charles Wood
Charles Wood University of Nebraska–Lincoln
Dirk P. Dittmer
Dirk P. Dittmer University of North Carolina at Chapel Hill
Glen N. Barber
Glen N. Barber University of Miami
Lawrence M. Weiss
Lawrence M. Weiss City Of Hope National Medical Center
Lee Ratner
Lee Ratner Washington University in St. Louis
Lawrence H. Boise
Lawrence H. Boise Emory University
Michael Dale Lairmore
Michael Dale Lairmore University of California, Davis
Blossom Damania
Blossom Damania University of North Carolina at Chapel Hill
Bruce J. Dezube
Bruce J. Dezube Beth Israel Deaconess Medical Center
Joseph R. Berger
Joseph R. Berger University of Pennsylvania

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in expanding their expertise beyond immunology, nursing offers several promising online degree options. Many students find that some of the easy nurse practitioner programs to get into provide flexible pathways to enter the nursing field efficiently, balancing work and study commitments.

Specifically, Psychiatric Mental Health Nurse Practitioner (PMHNP) programs have grown in popularity due to the increasing demand for mental health services. When researching options, it's essential to consider programs known for the best pmhnp programs with strong clinical placement rates, ensuring practical experience alongside academic learning.

Cost is another critical factor for many aspiring nurses. Fortunately, several affordable pmhnp programs offer quality education without the financial burden often associated with advanced degrees.

Completing advanced nursing degrees such as a Doctor of Nursing Practice (DNP) can lead to rewarding careers, often reflected in competitive earnings. Understanding the doctor of nursing practice salary variations across states can help prospective students make informed decisions about where to study and work.

Best Scientists Citing William J. Harrington